CRISPR and CRISPR-associated (Cas) Genes Market 2028 By Product, Application, End User and Geography | The Insight Partners

report image

CRISPR and CRISPR-associated (Cas) Genes Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Vector-based Cas , DNA-free Cas); Application (Genome Engineering, Disease models, Functional Genomics, Knockdown/activation, Others); End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) and Geography

Report Code: TIPRE00006876 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming


CRISPR and CRISPR-Associated (Cas) Genes are genome editing tools that allow scientists to make changes to DNA. CRISPR-Cas9 stands for CRISPR-associated protein 9 and clustered regularly interspaced short palindromic repeats. CRISPR and CRISPR-Associated (Cas) Genes have gained a lot of popularity in recent years because they offer genome editing methods that are cheaper, faster, more accurate, and more effective.


The "Global CRISPR and CRISPR-Associated (Cas) Genes Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the CRISPR and CRISPR-associated (Cas) genes market with detailed market segmentation by product, application and end user. The report provides key statistics on the market status of the leading CRISPR and CRISPR-associated (Cas) genes market players and offers key trends and opportunities in the market.


  •   Based on product the market is segmented as, vector-based Cas and DNA-free Cas.
  •   Based on application the market is segmented as, genome engineering, disease models, functional genomics, knockdown/activation and others.
  •   Based on end user the market is segmented as, biotechnology and pharmaceutical companies, academic and government research institutes, contract research organizations.


  •   Advancements in biopharmaceutical and pharmaceutical industries is the key driver for the market growth.
  •   Rising prevalence of genetic as well as chronic disorders along with increasing adoption of CRISPR.
  •   Increasing utilization of genome editing technologies is also expected to spur the market growth.


  •   However, presence of intense competition among the market players along with high cost associated with the study are likely to restrain market growth during the forecast period.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The CRISPR and CRISPR-associated (Cas) genes market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the CRISPR and CRISPR-associated (Cas) genes market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the CRISPR and CRISPR-associated (Cas) genes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from CRISPR and CRISPR-associated (Cas) genes market are anticipated to lucrative growth opportunities in the future with the rising demand for CRISPR and CRISPR-associated (Cas) genes in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the CRISPR and CRISPR-associated (Cas) genes market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Merck KGaA
  •   Bio-Rad Laboratories, Inc
  •   CRISPR Therapeutics
  •   Thermo Fisher Scientific, Inc.
  •   Mirus Bio LLC
  •   Editas Medicine
  •   Takara Bio Inc
  •   Horizon Discovery Ltd
  •   Lonza
  •   Intellia Therapeutics, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

- Merck KGaA
- Bio-Rad Laboratories, Inc
- CRISPR Therapeutics
- Thermo Fisher Scientific, Inc.
- Mirus Bio LLC
- Editas Medicine
- Takara Bio Inc
- Horizon Discovery Ltd
- Lonza
- Intellia Therapeutics, Inc.
- GenScript
- Synthego
- Mammoth Biosciences
- Beam Therapeutics
- Hera BioLabs
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount